Statement of Changes in Beneficial Ownership (4)
21 January 2023 - 10:01AM
Edgar (US Regulatory)
FORM 4
[ ] Check this box if no longer subject to Section
16. Form 4 or Form 5 obligations may continue. See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL
OWNERSHIP OF SECURITIES
|
OMB
APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5 |
|
Filed pursuant to Section 16(a) of the
Securities Exchange Act of 1934 or Section 30(h) of the Investment
Company Act of 1940
|
|
1. Name
and Address of Reporting Person * KAO JOHN E |
2. Issuer Name and Ticker or Trading
Symbol Alignment Healthcare, Inc. [ ALHC ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)__X__
Director _____
10% Owner
__X__ Officer (give title
below) _____ Other
(specify below)
Chief Executive Officer |
(Last)
(First)
(Middle)
1100 W. TOWN & COUNTRY RD., SUITE 1600 |
3. Date of Earliest Transaction (MM/DD/YYYY)
1/18/2023
|
(Street)
ORANGE, CA 92868
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or
Beneficially Owned
|
1.Title of Security
(Instr. 3) |
2. Trans. Date |
2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following
Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) |
7. Nature of Indirect Beneficial Ownership (Instr.
4) |
Code |
V |
Amount |
(A) or (D) |
Price |
Common Stock |
1/18/2023 |
|
S(1) |
|
1100 |
D |
$13.0091 (2) |
2723100 |
I |
See Footnote (3) |
Common Stock |
|
|
|
|
|
|
|
2420380 |
D |
|
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible
securities)
|
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative
Security |
3. Trans. Date |
3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or
Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying
Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially
Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct
(D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr.
4) |
Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Explanation of
Responses: |
(1) |
The sales reported in this
Form 4 were effected pursuant to a Rule 10b5-1 trading plan
previously adopted by the reporting person. |
(2) |
The reported price in column
4 is a weighted-average price. Shares were sold in multiple
transactions at a per share price ranging from $13.00 to $13.05.
The reporting person undertakes to provide to Alignment Healthcare,
Inc., any security holder of Alignment Healthcare, Inc., or the
staff of the Securities and Exchange Commission, upon request, full
information regarding the number of shares sold at each price
within the range. |
(3) |
Represents securities held
by JEK Trust, dated February 8, 2021, of which Mr. Kao is the
trustee. |
Reporting
Owners
|
Reporting Owner Name / Address |
Relationships
|
Director |
10% Owner |
Officer |
Other |
KAO JOHN E
1100 W. TOWN & COUNTRY RD., SUITE 1600
ORANGE, CA 92868 |
X |
|
Chief Executive Officer |
|
Signatures
|
/s/ Richard A. Cross, as Attorney-in-Fact, for
John E. Kao |
|
1/20/2023 |
**Signature of Reporting
Person |
Date |
Reminder: Report on a separate line for each class
of securities beneficially owned directly or
indirectly. |
* |
If the form is filed by more than one
reporting person, see Instruction 4(b)(v). |
** |
Intentional misstatements or omissions
of facts constitute Federal Criminal Violations. See 18
U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: |
File three copies of this Form, one of
which must be manually signed. If space is insufficient, see
Instruction 6 for procedure. |
Persons who respond to the collection of information
contained in this form are not required to respond unless the form
displays a currently valid OMB control number. |
Alignment Healthcare (NASDAQ:ALHC)
Historical Stock Chart
From Feb 2023 to Mar 2023
Alignment Healthcare (NASDAQ:ALHC)
Historical Stock Chart
From Mar 2022 to Mar 2023